Mankind Pharma Ltd. share price target

Name: Latest research reports of Mankind Pharma Ltd. authored by Centrum Broking and published by - Trendlyne research reports.
Item: Mankind Pharma Ltd.
Rating: 5
Author: Centrum Broking

Mankind Pharma Ltd. has an average share price target of 2840.50. The consensus estimate represents an upside of 10.53% from the last price of 2569.80. View 5 reports from 2 analysts offering long-term price targets for Mankind Pharma Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	17 Sep 2025	Mankind Pharma	Consensus Share Price Target	2569.80	2799.65	-	8.94	buy	pdf Detailed Estimates
	20 Apr 2023	Mankind Pharma	Centrum Broking	2569.80				IPO Subscribe	pdf post cache		Broker Report Domestic leader gears up for listing Centrum Broking Mankind is a well?known player in the domestic pharma market (with 97.6% of sales), and is 4th largest in terms of sales and 3rd largest in terms of sales volume as on Dec’22 MAT. About 36 brands in the Pharma business, which has sales over Rs500mn, with strong brand positioning. In the consumer segment, it has leading brands i.e Manforce, Prega News, Unwanted?72, which are having significant market share in their respective categories. pdf Copy Link Share on Share on Share on Share on Alert

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Mankind Pharma Ltd. share price target

Mankind Pharma Ltd. has an average share price target of 2840.50. The consensus estimate represents an upside of 10.53% from the last price of 2569.80. View 5 reports from 2 analysts offering long-term price targets for Mankind Pharma Ltd..

Domestic leader gears up for listing

Advisor Screeners